Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

26 August 2014 : Original article  

Local Airway Anesthesia Attenuates Hemodynamic Responses to Intubation and Extubation in Hypertensive Surgical Patients

You-Fan MengBE, Guang-Xiao CuiCE, Wei GaoDF, Zhi-Wen LiA

DOI: 10.12659/MSM.890703

Med Sci Monit 2014; 20:1518-1524

Abstract

BACKGROUND: The aim of this study was to evaluate the effects of topical ropivacaine anesthesia on hemodynamic responses during intubation and extubation of hypertensive patients.

MATERIAL AND METHODS: One hundred fifty patients with hypertension ASA II-III were scheduled for noncardiac operations. Patients were divided into 3 groups: a control group receiving 5 ml saline, and 2 groups receiving topical anesthesia with 100 mg lidocaine or 37.5 mg ropivacaine. Hemodynamic responses, including blood pressure and heart rate (HR), were recorded at baseline (T0), before intubation (T1), during tracheal intubation (T2), 2 min after intubation (T3), upon eye opening on verbal commands (T4), during tracheal extubation (T5), and 2 min after extubation (T6). Patients were injected with urapidil 5 mg during intubation and extubation if their systolic blood pressure (SBP) was ≥160 mmHg or diastolic blood pressure (DBP) was ³90 mmHg, and esmolol 10 mg when HR was ≥90 bpm.

RESULTS: During extubation, the total dosages of urapidil and esmolol were significantly higher in the saline than in the lidocaine or ropivacaine groups, and were significantly lower in the ropivacaine than in the lidocaine group. At T2, SBP, SBP, MAP, and HR were lower in the lidocaine and ropivacaine groups than in the saline group, but the differences were not significant. From T4 to T6, SBP, DBP, MAP, and HR were significantly lower in the ropivacaine group than in the other 2 groups (P<0.05 each).

CONCLUSIONS: Topical lidocaine and ropivacaine anesthesia can effectively reduce hemodynamic responses during intubation, with ropivacaine better at inhibiting hemodynamic changes at emergence in hypertensive patients.

Keywords: Amides - pharmacology, Airway Extubation, Anesthesia, Local, Antihypertensive Agents - therapeutic use, Arterial Pressure - drug effects, Demography, Diastole - drug effects, Dose-Response Relationship, Drug, Heart Rate - drug effects, Hemodynamics - drug effects, Hypertension - surgery, Intubation, Intratracheal, Lidocaine - pharmacology, Piperazines - therapeutic use, Propanolamines - therapeutic use, Systole - drug effects

Add Comment 0 Comments

Editorial

01 March 2025 : Editorial  

Editorial: The World Health Organization (WHO) Updated List of Emerging and Potentially Pandemic Pathogens Includes Yersinia pestis as Plague Vaccines Await Clinical Trials

Dinah V. Parums

DOI: 10.12659/MSM.948672

Med Sci Monit 2025; 31:e948672

0:00

In Press

Clinical Research  

Impact of Cholecalciferol Supplementation on Radiotherapy Outcomes in Advanced Cervical Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.945964  

Clinical Research  

Inflammatory Biomarkers in Smokers: Implications for Ligamentum Flavum Hypertrophy

Med Sci Monit In Press; DOI: 10.12659/MSM.947508  

Clinical Research  

Balancing Image Quality and Iodine Intake: Insights from CT Spectral Imaging of the Portal Vein

Med Sci Monit In Press; DOI: 10.12659/MSM.947391  

Review article  

Regulatory Efforts and Health Implications of Energy Drink Consumption by Minors in Poland

Med Sci Monit In Press; DOI: 10.12659/MSM.947124  

Most Viewed Current Articles

17 Jan 2024 : Review article   7,216,875

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

16 May 2023 : Clinical Research   702,406

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Mar 2024 : Editorial   27,844

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...

DOI :10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

28 Jan 2024 : Review article   22,117

A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and Future

DOI :10.12659/MSM.943912

Med Sci Monit 2024; 30:e943912

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750